Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

Annals of Internal Medicine

Volumn 111, Issue 4, 1989, Pages 273-279

  McGuire, W P ^a   Rowinsky, E K ^a   Rosenhein, N B ^a   Grumbine, F C ^a   Ettinger, D S ^a   Armstrong, D K ^a   Donehower, R C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PACLITAXEL;

ADVERSE DRUG REACTION; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOXICITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; OVARY CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS;

EID: 0024327106     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-111-4-273     Document Type: Article

References (0)